tipranavir tpv tipranavir disodium nonpeptidic protease inhibitor pi manufactured boehringer ingelheim trade name aptivus ˈæptɪvəs aptivəs administered ritonavir combination therapy treat hiv infectioncitation needed tipranavir ability inhibit replication viruses resistant protease inhibitors recommended patients resistant treatments resistance tipranavir seems require multiple tipranavir approved food drug administration fda june approved pediatric use june tipranavir taken combination ritonavir antiretroviral drugs approved treatmentnaïve like lopinavir atazanavir potent effective salvage therapy patients drug resistance however side effects tipranavir may severe antiretrovirals side effects include intracranial hemorrhage hepatitis hepatic decompensation hyperglycemia diabetes mellitus drug also shown cause increases total cholesterol aptivus labeling black box warning regarding hepatotoxicity intracranial httpsenwikipediaorgwikitipranavir